Why is Kwality Pharma falling/rising?

As of 10-Jun, Kwality Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 988.45, which reflects a rise of Rs 79.5 or 8.75%. The stock has shown a strong performance today, outperforming its sector by 8.23% and reversing a trend after three consecutive days of decline. It reached an intraday high of Rs 1030, indicating significant volatility with a wide trading range of Rs 142.25. Over the past week, the stock has gained 6.24%, and it has outperformed the benchmark Sensex, which rose by only 2.05%. Positive factors contributing to this rise include a strong ability to service debt, impressive net profit growth of 241.51%, and a bullish technical trend supported by favorable indicators such as MACD and Bollinger Bands.
In the broader market context, Kwality Pharmaceuticals has demonstrated superior returns compared to the Sensex over various periods, including a 36.36% increase over the past month versus the Sensex's 3.70%. Despite the positive short-term performance, there are concerns regarding long-term growth due to a decline in net sales and operating profit over the last five years. Additionally, the lack of domestic mutual fund investment may indicate caution among institutional investors regarding the stock's valuation or business fundamentals. Overall, while the stock is currently rising due to strong recent performance and positive financial indicators, the long-term outlook remains mixed due to underlying growth challenges.